Equity Incentive Plans |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Incentive Plans | Equity Incentive Plans The following table is a summary of the Company’s stock options outstanding as of March 31, 2026, and changes therein during the three months then ended.
On February 4, 2026, the Company granted to directors and employees, under the 2019 Equity Incentive Plan, 201,172 cash-settled restricted stock units with a total grant date fair value of $2.8 million. Of these grants, 35,064 vest one year from the date of grant and 166,108 vest in equal installments over a three-year period beginning one year from the date of grant. As the awards will be settled in cash they are classified as liabilities on the consolidated balance sheets. During the three months ended March 31, 2026 and 2025, the Company recorded compensation expense of $204,000 and $0, respectively, related to the above plan. The following is a summary of the status of the Company’s restricted stock awards and performance-based restricted stock units at March 31, 2026, and changes therein during the three months then ended.
Expected future stock award expense related to the non-vested restricted share awards as of March 31, 2026, was $1.8 million over a weighted average period of 1.5 years. Expected future stock award expense related to the non-vested performance share awards as of March 31, 2026, was $581,000 over a weighted average period of 1.4 years. During the three months ended March 31, 2026, and March 31, 2025, the Company recorded $553,000 and $765,000, respectively, of stock-based compensation related to the above plan.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||